Delivery Order SPE2DB22D1202-SPE2DB24FUSU7
Award Date
3/6/24
Potential Completion Date
3/7/24
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $31,160.74 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical product. The contract has a completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The $20,066.18 firm-fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract has an ultimate completion date of May 1, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,568.72 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with a completion date of June 1, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Dupixent 300 mg/2 ml syringe (2 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The $25,934.80 firm-fixed-price delivery order has an ultimate completion date of October 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ85R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,198.83 firm-fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $43,094.75 Firm Fixed Price Delivery Order contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The contract has a performance period through May 6, 2024 and was awarded on May 3, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $9,928.69 and is a delivery order for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price type with a period of performance through May 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,304.72 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes and has an ultimate completion date of December 5, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including Dupixent 300 mg/2 ml pens, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm-fixed price of $4,570.80 and an ultimate completion date of October 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,917.67 for the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 30, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...